LGBT Cancer Project

Therapeutic Areas: Oncology | Family Medicine

Metastatic Cancer Clinical Trials

A listing of Metastatic Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

NEW

Research Center
Tucson Arizona

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Scottsdale Arizona 85258

A clinical trial seeking patients for a research study for the treatment of Locally Advanced Cancer or Metastatic Cancer

Scottsdale Arizona 85258

A clinical trial seeking patients for a research study of CB-1158 and Nivolumab

Tucson Arizona 85724

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

California

Stanford University Medical Center
Palo Alto California 94304

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

NEW

Research Center
San Diego California

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

NEW

Research Center
San Francisco California

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Sarcoma Oncology Research Center
Santa Monica California 90403

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Incyte Corporation
Whittier California

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

La Jolla California 92093

A Phase 2 clinical study for patients with Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Los Angeles California 90033

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Los Angeles California 90025

A clinical trial to evaluate treatments using INCAGN01876 for patients with Advanced Cancer or Metastatic Cancer

San Diego California 92123

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

San Francisco California 94143

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

San Francisco California 94143

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

NEW

Research Center
Glenwood Springs Colorado

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Denver Colorado 80045

A Phase 1 clinical study for patients with Metastatic Cancer, Solid Tumor, Advanced Cancer or NonHodgkin Lymphoma

Connecticut

New Haven Connecticut 06511

A clinical trial to evaluate treatments using INCAGN01876 for patients with Advanced Cancer or Metastatic Cancer

District of Columbia

MedStar Washington Hospital Center
Washington District of Columbia 20010

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Washington District of Columbia 20007

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Florida

Mayo Clinic of Jacksonville
Jacksonville Florida 32224

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

NEW

Research Center
Miami Beach Florida

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Fort Myers Florida 33916

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Gainesville Florida 33612

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

St. Petersburg Florida 33705

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Georgia

NEW

Research Center
Atlanta Georgia

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Georgia Cancer Specialists
Sandy Springs Georgia 30342

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Memorial University Medical Center
Savannah Georgia 31404

SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer

Atlanta Georgia 30322

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Illinois

AMITA Health
Arlington Heights Illinois 60005

Evaluation of Targeted Radiofrequency Ablation and Vetebral Augmentation prior to or following Radiation Therapy to Treat Painful Metastatic Vetebral Body Tumor(s) [The STARRT Study]

Northwestern University Feinburg School of Medicine
Chicago Illinois 60611

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Maywood Illinois 60153

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Iowa

University of Iowa Hospital and Clinics
Iowa City Iowa 52242

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Maryland

NEW

Research Center
Baltimore Maryland

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

NEW

Research Center
Burlington Massachusetts

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Solid Tumors, CNS Tumors or Neuroblastoma

Boston Massachusetts 02215

A clinical trial to evaluate treatments using INCAGN01876 for patients with Advanced Cancer or Metastatic Cancer

Michigan

Detroit Michigan 48201

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Grand Rapids Michigan 49503

A Phase 1 clinical study for patients with Metastatic Cancer, Solid Tumor, Advanced Cancer or NonHodgkin Lymphoma

Grand Rapids Michigan

Patients are needed to participate in a clinical research study of MGA012 to evaluate Locally Advanced Solid Tumors or Metastatic Solid Tumors

Minnesota

Mayo Clinic Rochester
Rochester Minnesota 10029

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

Missouri

Washington University in St. Louis
St. Louis Missouri 63110

Phase 2 Trial of CMB305 and Atezolizumab in Patients with Sarcoma (IMDZ-C232)

St. Louis Missouri 63110

A clinical trial to evaluate treatments for patients with Biliary Tract Cancer, Metastatic Cancer or Advanced Cancer

Nebraska

NEW

Research Center
Omaha Nebraska

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Research Center
Omaha Nebraska

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Research Center
Omaha Nebraska

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

Nevada

Research Center
Las Vegas Nevada

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations